Modified CMV Vaccine Appears Effective In Recipients Of Allogeneic Hematopoietic Stem Cell Transplant, Study Suggests
February 27, 2020
Infectious Disease Advisor (2/26, Gupta) reports that “Triplex, a modified version of the recombinant attenuated poxvirus vaccine engineered to induce a virus-specific T-cell response to control cytomegalovirus (CMV) in recipients of allogeneic hematopoie...